Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Tharimmune ( (THAR) ).
On October 9, 2025, Tharimmune, Inc. held a special meeting where stockholders approved several key proposals. These included an amendment to increase the number of shares of common stock reserved under the 2023 Omnibus Equity Incentive Plan to 2,000,000 shares, an authorization for the board to potentially increase the total authorized shares of common stock to up to 1,000,000,000, and permission to issue securities in non-public offerings. These decisions reflect strategic moves to enhance Tharimmune’s operational flexibility and potential market positioning.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,000,443
Technical Sentiment Signal: Hold
Current Market Cap: $16.63M
For a thorough assessment of THAR stock, go to TipRanks’ Stock Analysis page.